- INVESTORS
- CONTACT US
Research Status
PIPELINE
Research Status
With TOFPOMICS®, ONCOBIX has developed a range of pipelines for various diseases. We are expanding our pipelines through continuous dedication to research.
- Objectives Per Task : Identify and discover new best-in-kinase drugs
| Project | Target/Indication | Discovery | Non-Clinical | Clinical trials | |||
|---|---|---|---|---|---|---|---|
| Hit | Lead | Candidate | IND enabling | Phase I | Phase II/III | ||
| OBX02 |
ALK/EGFR |
||||||
| OBX10 |
Undisclosed |
||||||
| OBX08 |
EGFR Exon 20 insertion |
||||||
| OBX13 |
Undisclosed |
||||||
| OBX16 |
Undisclosed |
||||||
| OBX09 |
Undisclosed |
||||||
MFDS, Ministry of Food and Drug Safety (Korea); IND, Investigational new drug application
ALK, Anaplastic lymphoma kinase; EGFR, epidermal growth factor receptor; epithelial–mesenchymal transition; IPF, idiopathic pulmonary fibrosis;
Development Stage: Hit compounds => Lead compounds => Candidate compounds